2019
DOI: 10.1097/01.hs9.0000564404.98482.76
|View full text |Cite
|
Sign up to set email alerts
|

Ps1536 Empirical Antibiotic Therapy for Neutropenic Fever After Allogeneic Stem Cell Transplantation Influences Graft‐versus‐host Disease‐related Mortality

Abstract: Background: About 30% of Hodgkin Lymphoma (HL) patients are refractory to induction therapy or relapse. Standard salvage treatment is often followed by high-dose chemotherapy and autologous stem cell transplantation (ASCT) if at least a partial remission is achieved. However 30-50% of relapsed-refractory (R/R) patients fail to achieve PR. Recently the PD-1 targeting antibody Nivolumab has shown promising activity in HL patients relapsed after ASCT but the expected CR rate is only about 20%. Administration of n… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles